Prostate Cancer - Results from #27800

Relationship between prostate-specific antigen, age, and body mass index in a prostate cancer screening population - Abstract June 7, 2011

Emerging therapeutic approaches in the management of metastatic castration-resistant prostate cancer - Abstract June 7, 2011

Evolving standards in the treatment of docetaxel-refractory castration-resistant prostate cancer - Abstract June 7, 2011

Zoledronic acid to prevent bone loss in Chinese men receiving androgen deprivation therapy for prostate cancer - Abstract June 7, 2011

A large cohort study of long-term acetaminophen use and prostate cancer incidence - Abstract June 7, 2011

Antifungal drug delays need for chemo in advanced prostate cancer June 7, 2011

CURy 2011 - Biomarkers in prostate cancer - Slide Presentation June 7, 2011

Effects of androgen receptor and androgen on gene expression in prostate stromal fibroblasts and paracrine signaling to prostate cancer cells - Abstract June 7, 2011

Focal therapy with high-intensity focused ultrasound for prostate cancer in the elderly. A feasibility study with 10 years follow-up - Abstract June 6, 2011

Preliminary analysis of the feasibility and safety of salvage robot-assisted radical prostatectomy after radiation failure: Multi-institutional perioperative and short-term functional outcomes - Abstract June 6, 2011

Proton radiotherapy for prostate cancer is not associated with post-treatment testosterone suppression - Abstract June 6, 2011

Prostate needle biopsy examination by means of virtual microscopy - Abstract June 6, 2011

The role of 3-dimensional mapping biopsy in decision making for treatment of apparent early stage prostate cancer - Abstract June 6, 2011

Risk of death from prostate cancer after radical prostatectomy or brachytherapy in men with low or intermediate risk disease - Abstract June 6, 2011

Statin use and risk of prostate cancer in a population of men who underwent biopsy - Abstract June 6, 2011

Advancements in MR imaging of the prostate: From diagnosis to interventions - Abstract June 6, 2011

Role of neuroendocrine cells in prostate cancer progression - Abstract June 6, 2011

Data presented at the 47th American Society of Clinical Oncology (ASCO) annual meeting demonstrate the potential of circulating tumor cells (CTC) as a biomarker for metastatic prostate cancer clinical trials June 6, 2011

Editor's Commentary - The genomic complexity of primary human prostate cancer June 6, 2011

Effect of age, family history of prostate cancer, prostate enlargement and seasonality on PSA levels in a contemporary cohort of healthy Italian subjects - Abstract June 5, 2011

Page 1391 of 1437